MetLife Statistics
Total Valuation
MetLife has a market cap or net worth of $58.38 billion. The enterprise value is $102.98 billion.
Important Dates
The last earnings date was Wednesday, February 5, 2025, after market close.
| Earnings Date | Feb 5, 2025 |
| Ex-Dividend Date | Feb 4, 2025 |
Share Statistics
MetLife has 681.23 million shares outstanding. The number of shares has decreased by -6.72% in one year.
| Current Share Class | 681.23M |
| Shares Outstanding | 681.23M |
| Shares Change (YoY) | -6.72% |
| Shares Change (QoQ) | -0.82% |
| Owned by Insiders (%) | 0.21% |
| Owned by Institutions (%) | 75.42% |
| Float | 568.38M |
Valuation Ratios
The trailing PE ratio is 14.43 and the forward PE ratio is 9.06. MetLife's PEG ratio is 0.71.
| PE Ratio | 14.43 |
| Forward PE | 9.06 |
| PS Ratio | 0.85 |
| Forward PS | 0.77 |
| PB Ratio | 2.15 |
| P/TBV Ratio | 3.27 |
| P/FCF Ratio | 4.00 |
| P/OCF Ratio | 4.00 |
| PEG Ratio | 0.71 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 16.45, with an EV/FCF ratio of 7.05.
| EV / Earnings | 24.37 |
| EV / Sales | 1.45 |
| EV / EBITDA | 16.45 |
| EV / EBIT | 18.57 |
| EV / FCF | 7.05 |
Financial Position
The company has a current ratio of 1.54, with a Debt / Equity ratio of 2.33.
| Current Ratio | 1.54 |
| Quick Ratio | 1.28 |
| Debt / Equity | 2.33 |
| Debt / EBITDA | 10.03 |
| Debt / FCF | 4.43 |
| Interest Coverage | 5.35 |
Financial Efficiency
Return on equity (ROE) is 15.34% and return on invested capital (ROIC) is 3.67%.
| Return on Equity (ROE) | 15.34% |
| Return on Assets (ROA) | 0.51% |
| Return on Invested Capital (ROIC) | 3.67% |
| Return on Capital Employed (ROCE) | 0.88% |
| Revenue Per Employee | $1.58M |
| Profits Per Employee | $93,911 |
| Employee Count | 45,000 |
| Asset Turnover | 0.10 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MetLife has paid $1.18 billion in taxes.
| Income Tax | 1.18B |
| Effective Tax Rate | 20.95% |
Stock Price Statistics
The stock price has increased by +22.90% in the last 52 weeks. The beta is 1.03, so MetLife's price volatility has been similar to the market average.
| Beta (5Y) | 1.03 |
| 52-Week Price Change | +22.90% |
| 50-Day Moving Average | 83.47 |
| 200-Day Moving Average | 78.71 |
| Relative Strength Index (RSI) | 59.25 |
| Average Volume (20 Days) | 3,628,693 |
Short Selling Information
The latest short interest is 7.61 million, so 1.12% of the outstanding shares have been sold short.
| Short Interest | 7.61M |
| Short Previous Month | 7.40M |
| Short % of Shares Out | 1.12% |
| Short % of Float | 1.34% |
| Short Ratio (days to cover) | 1.99 |
Income Statement
In the last 12 months, MetLife had revenue of $70.98 billion and earned $4.23 billion in profits. Earnings per share was $5.94.
| Revenue | 70.98B |
| Gross Profit | 17.53B |
| Operating Income | 5.55B |
| Pretax Income | 3.69B |
| Net Income | 4.23B |
| EBITDA | 6.26B |
| EBIT | 5.55B |
| Earnings Per Share (EPS) | $5.94 |
Full Income StatementBalance Sheet
The company has $28.23 billion in cash and $64.66 billion in debt, giving a net cash position of -$44.59 billion or -$65.46 per share.
| Cash & Cash Equivalents | 28.23B |
| Total Debt | 64.66B |
| Net Cash | -44.59B |
| Net Cash Per Share | -$65.46 |
| Equity (Book Value) | 27.70B |
| Book Value Per Share | 39.82 |
| Working Capital | 25.19B |
Full Balance SheetCash Flow
| Operating Cash Flow | 14.60B |
| Capital Expenditures | n/a |
| Free Cash Flow | 14.60B |
| FCF Per Share | $21.43 |
Full Cash Flow StatementMargins
Gross margin is 24.69%, with operating and profit margins of 7.81% and 6.24%.
| Gross Margin | 24.69% |
| Operating Margin | 7.81% |
| Pretax Margin | 7.92% |
| Profit Margin | 6.24% |
| EBITDA Margin | 8.82% |
| EBIT Margin | 7.81% |
| FCF Margin | 20.57% |